AAAAAA

   
Results: 1-21 |
Results: 21
Preparation and properties of an alpha-1-protease inhibitor concentrate with high specific activity
Authors: Mattes, E Matthiessen, HP Turecek, PL Schwarz, HP
Citation: E. Mattes et al., Preparation and properties of an alpha-1-protease inhibitor concentrate with high specific activity, VOX SANGUIN, 81(1), 2001, pp. 29-36
Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases
Authors: Volkel, D Zimmermann, K Zerr, I Bodemer, M Lindner, T Turecek, PL Poser, S Schwarz, HP
Citation: D. Volkel et al., Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases, TRANSFUSION, 41(4), 2001, pp. 441-448
Deoxyribonucleic acid preparation in polymerase chain reaction genotyping of transgenic mice
Authors: Zimmermann, K Schwarz, HP Turecek, PL
Citation: K. Zimmermann et al., Deoxyribonucleic acid preparation in polymerase chain reaction genotyping of transgenic mice, COMPAR MED, 50(3), 2000, pp. 314-316
Sensitive single-stage PCR using custom-synthesized internal controls
Authors: Zimmermann, K Rieger, M Gross, P Turecek, PL Schwarz, HP
Citation: K. Zimmermann et al., Sensitive single-stage PCR using custom-synthesized internal controls, BIOTECHNIQU, 28(4), 2000, pp. 694
Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A
Authors: Reipert, BM Ahmad, RU Turecek, PL Schwarz, HP
Citation: Bm. Reipert et al., Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A, THROMB HAEM, 84(5), 2000, pp. 826-832
von Willebrand Disease in a pediatric-based population - Comparison of type 1 diagnostic criteria and use of the PFA-100 (R) and a von Willebrand factor/collagen-binding assay
Authors: Dean, JA Blanchette, VS Carcao, MD Stain, AM Sparling, CR Siekmann, J Turecek, PL Lillicrap, D Rand, ML
Citation: Ja. Dean et al., von Willebrand Disease in a pediatric-based population - Comparison of type 1 diagnostic criteria and use of the PFA-100 (R) and a von Willebrand factor/collagen-binding assay, THROMB HAEM, 84(3), 2000, pp. 401-409
Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor-deficient mice
Authors: Schwarz, HP Lenting, PJ Binder, B Mihaly, J Denis, C Dorner, F Turecek, PL
Citation: Hp. Schwarz et al., Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor-deficient mice, BLOOD, 95(5), 2000, pp. 1703-1708
In vivo inhibition of low density lipoprotein receptor-related protein improves survival of factor VIII in the absence of von Willebrand factor
Authors: Turecek, PL Schwarz, HP Binder, BR
Citation: Pl. Turecek et al., In vivo inhibition of low density lipoprotein receptor-related protein improves survival of factor VIII in the absence of von Willebrand factor, BLOOD, 95(11), 2000, pp. 3637-3638
Continuous infusion of FVIII and FIX concentrates: in vitro analysis of clinically relevant parameters
Authors: Thomas, KB Urbancik, W Turecek, PL Gritsch, H Schreiber, J Weber, A Schonhofer, W Strauss, M Linnau, Y Schoppmann, A
Citation: Kb. Thomas et al., Continuous infusion of FVIII and FIX concentrates: in vitro analysis of clinically relevant parameters, HAEMOPHILIA, 5(1), 1999, pp. 17-25
Strategies for recombinant Furin employment in a biotechnological process:complete target protein precursor cleavage
Authors: Preininger, A Schlokat, U Mohr, G Himmelspach, ME Stichler, V Kyd-Rebenburg, A Plaimauer, B Turecek, PL Schwarz, HP Wernhart, W Fischer, BE Dorner, F
Citation: A. Preininger et al., Strategies for recombinant Furin employment in a biotechnological process:complete target protein precursor cleavage, CYTOTECHNOL, 30(1-3), 1999, pp. 1-15
Phospholipid-bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivation
Authors: Varadi, K Siekmann, J Turecek, PL Schwarz, HP Marder, VJ
Citation: K. Varadi et al., Phospholipid-bound tissue factor modulates both thrombin generation and APC-mediated factor Va inactivation, THROMB HAEM, 82(6), 1999, pp. 1673-1679
Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF - A tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)
Authors: Gerritsen, HE Turecek, PL Schwarz, HP Lammle, B Furlan, M
Citation: He. Gerritsen et al., Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF - A tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP), THROMB HAEM, 82(5), 1999, pp. 1386-1389
Phenotypic expression of murine hemophilia
Authors: Muchitsch, EM Turecek, PL Zimmermann, K Pichler, L Auer, W Richter, G Gritsch, H Schwarz, HP
Citation: Em. Muchitsch et al., Phenotypic expression of murine hemophilia, THROMB HAEM, 82(4), 1999, pp. 1371-1373
Determination of the prevalence of fibrinogen Banks peninsula mutation (gamma 280Tyr -> Cys) by PCR
Authors: Zimmermann, K Turecek, PL Schwarz, HP
Citation: K. Zimmermann et al., Determination of the prevalence of fibrinogen Banks peninsula mutation (gamma 280Tyr -> Cys) by PCR, HAEMOSTASIS, 29(4), 1999, pp. 225-228
Characterization of factor VIII-knock out-mice: a new tool in biomedical research
Authors: Muchitsch, EM Pichler, L Turecek, PL Gritsch, H Richter, G Auer, W Schwarz, HP
Citation: Em. Muchitsch et al., Characterization of factor VIII-knock out-mice: a new tool in biomedical research, WIEN TIER M, 86(10), 1999, pp. 339-346
Preclinical evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease
Authors: Schwarz, HP Dorner, F Mitterer, A Mundt, W Schlokat, U Pichler, L Turecek, PL
Citation: Hp. Schwarz et al., Preclinical evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease, WIEN KLIN W, 111(5), 1999, pp. 181-191
Factor Xa and prothrombin: Mechanism of action of FEIBA
Authors: Turecek, PL Varadi, K Gritsch, H Auer, W Pichler, L Eder, G Schwarz, HP
Citation: Pl. Turecek et al., Factor Xa and prothrombin: Mechanism of action of FEIBA, VOX SANGUIN, 77, 1999, pp. 72-79
Evidence for extracellular processing of pro-von Willebrand factor after infusion in animals with and without severe von Willebrand disease
Authors: Turecek, PL Pichler, L Auer, W Eder, G Varadi, K Mitterer, A Mundt, W Schlokat, U Dorner, F Drouet, LO Roussi, J van Mourik, JA Schwarz, HP
Citation: Pl. Turecek et al., Evidence for extracellular processing of pro-von Willebrand factor after infusion in animals with and without severe von Willebrand disease, BLOOD, 94(5), 1999, pp. 1637-1647
Genotyping of the prion protein gene at codon 129
Authors: Zimmermann, K Turecek, PL Schwarz, HP
Citation: K. Zimmermann et al., Genotyping of the prion protein gene at codon 129, ACT NEUROP, 97(4), 1999, pp. 355-358
The determination of von Willebrand factor activity by collagen binding assay
Authors: Siekmann, J Turecek, PL Schwarz, HP
Citation: J. Siekmann et al., The determination of von Willebrand factor activity by collagen binding assay, HAEMOPHILIA, 4, 1998, pp. 15-24
Evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease
Authors: Schwarz, HP Dorner, F Mitterer, A Mundt, W Schlokat, U Pichler, L Turecek, PL
Citation: Hp. Schwarz et al., Evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease, HAEMOPHILIA, 4, 1998, pp. 53-62
Risultati: 1-21 |